Vertex Pharmaceuticals Incorporated (VRTX) Stock Price: $445.77+2.81 (+0.63%)
The total return cagr for Vertex Pharmaceuticals Incorporated (VRTX) stock is -0.09% over the past 12 months. The 3 year average growth rate is 10.09% and the 5 year cagr is 15.86%. Total return includes dividends reinvested.
The closing share price for Vertex Pharmaceuticals Incorporated (VRTX) stock was $445.77 for Tuesday, June 9, 2026, up +0.63% from the previous day.
VRTX Price Chart
VRTX Key Metrics
See All MetricsVRTX Earnings Preview
Next Earnings Date
Aug 3, 2026
55 days away
EPS Estimate
4.73
Revenue Est.
$3.21B
Last Quarter Results
EPS
$4.47
vs Estimate
$4.31
Revenue
$2.99B
vs Estimate
$2.99B
VRTX Analyst Ratings
Consensus Rating
Based on 29 analysts
Average Price Target
$548.69
+23.1% upside
Low
$330.00
Current
$445.77
High
$641.00
VRTX Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $4.88 | N/A | 6 |
| Q2 2027 | N/A | $5.17 | N/A | 6 |
| Q3 2027 | N/A | $5.66 | N/A | 6 |
| Q4 2027 | N/A | $6.03 | N/A | 6 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $21.62 | N/A | 18 |
| FY 2028 | N/A | $25.00 | N/A | 14 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $3.31B | N/A | 6 |
| Q2 2027 | N/A | $3.48B | N/A | 6 |
| Q3 2027 | N/A | $3.63B | N/A | 6 |
| Q4 2027 | N/A | $3.75B | N/A | 6 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $14.27B | N/A | 18 |
| FY 2028 | N/A | $15.83B | N/A | 14 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
VRTX Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1VRTX | $113.14B | $445.77 | +0.63% | -0.09% | +15.86% | +17.03% |
VRTX Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt